demonstrated that colorectal cancer cells secreting high levels of miR-208b stimulated the expansion of Tregs by targeting the programmed cell death factor 4 (PDCD4) and favored resistance to oxaliplatin (22). The gene discussed is PDCD4; the disease is colorectal cancer.